Efficacy and Safety of Bruton Tyrosine Kinase Inhibitor Monotherapy Compared with Combination Therapy for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis.

Nguyen, Thi Thuy; Nhu, Nguyen Thanh; Tran, Van Khoi; Nguyen, Tran Thuc Huan; Lin, Chiou-Feng

Nguyen, Thi Thuy; Nhu, Nguyen Thanh; Tran, Van Khoi; Nguyen, Tran Thuc Huan; Lin, Chiou-Feng.

Afiliación

Nguyen TT; International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Nhu NT; Department of Oncology, Hue University of Medicine and Pharmacy, Hue University, Hue 49120, Vietnam.
Tran VK; International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Nguyen TTH; Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho 94117, Vietnam.
Lin CF; International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Cancers (Basel) ; 15(7)2023 Mar 27.

Article en En | MEDLINE | ID: mdl-37046657

Palabras clave

Bruton tyrosine kinase inhibitor; chronic lymphocytic leukemia; meta-analysis; small lymphocytic lymphoma; systematic review

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google